Table:
begin	end	state
1	52	cytoplasmic
53	71	transmembrane
72	85	non-cytoplasmic
86	108	transmembrane
109	119	cytoplasmic
120	140	transmembrane
141	146	non-cytoplasmic
147	172	transmembrane
173	184	cytoplasmic
185	208	transmembrane
209	219	non-cytoplasmic
220	239	transmembrane
240	272	cytoplasmic
273	292	transmembrane
293	309	non-cytoplasmic
310	330	transmembrane
331	338	cytoplasmic
339	357	transmembrane
358	362	non-cytoplasmic
363	381	transmembrane
382	400	cytoplasmic
401	427	transmembrane
428	432	non-cytoplasmic
433	450	transmembrane
451	462	cytoplasmic

Input:
>WP_079188988.1 NCBI__GCF_001906585.1:WP_079188988.1
MSDQPSLTGQPAAPPISSASPIMSATDVAGPPEVGVDTSVAPSTRRRVVAASFIGNFVEW
FDYAAYGYLAATISTVFFPDTDRTTALLATFVVFAVSFFVRPIGGFVWGHIGDKVGRRNA
LSLSIVIMSVATFCIALLPTYRAVGLLAPLLLLLVRIVQGFSASGEYAGASAFLVEYAPP
GRRGLYASVVPASTASGLLLGSLLAALLSGILSDGQMHSWGWRLPFLLAAPMGLIGRYIR
LRLEDTPAFRALEDQEVAPTPAKQMLRANRRPLVLAMGATVLNAVAFYMLLSYMPTYLSE
ELHFGATESFLTTTVSLAAYIACIFFTGLASDRFGRKKMLITASVLFTVCTVPAFMLLDG
AGLLTVIVIQVLLGGMLSLNDGTLPSFLAEQFPTRVRYSGFAISFNMANALFGGTAAFVA
TLLISWTGSSLSPAWYLAVAALVSLWAVLSSKETSREPLRES

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server